How semaglutide affects your bowel movements — and what to do about it

It starts in week one, here's what's actually happening

Picture this: you've collected your first Wegovy pen, you're three days in, and the bathroom schedule you've had for years has gone completely rogue. One day loose, the next nothing. You're not doing anything wrong. This is the gut adjusting to a medicine that fundamentally changes the speed of digestion.

Semaglutide is a GLP-1 receptor agonist, and if you want to understand how semaglutide works and what it's used for, the detail helps make sense of the side effects. One of its core mechanisms is slowing gastric emptying, food moves more slowly from the stomach into the small intestine. That slowdown affects the entire digestive cascade: stool consistency, transit time, and urgency all shift. In some people the slow-down produces constipation; in others, particularly early on, the gut responds with loose stools or diarrhoea as it recalibrates. Both can happen in the same person across the same fortnight.

The NHS semaglutide patient information page lists diarrhoea, constipation, nausea, vomiting, and stomach pain among the most common side effects. None of this is unusual, and none of it means the medicine isn't working. What matters is whether the symptoms are manageable and settling, and whether you're staying hydrated through it.

If you are using the Wegovy injection and find your GI symptoms peak then ease off, that pattern is typical. The 0.25mg starting dose is low deliberately, your system gets time to adjust before the next step up.

The difference between diarrhoea and constipation on semaglutide, and why both happen

The same mechanism that slows gastric emptying can produce opposite outcomes in different people, which confuses a lot of patients. Here's a straightforward way to think about it.

Rapid GI motility early in treatment (when the gut is reacting to a new medicine) can produce loose stools. The bowel hasn't yet learned to coordinate with the new pace. At the same time, semaglutide reduces appetite substantially, so you're eating less. Less food volume means less bulk moving through the colon, which contributes to constipation in others. Reduced water intake (common when appetite and thirst signals are both blunted) compounds this.

Fibre and fluid are the practical levers. Adequate dietary fibre (vegetables, pulses, wholegrains) supports normal stool bulk. Plain water, consumed steadily through the day, keeps transit from stalling. If constipation is an issue, a short walk after meals can also help gut motility; this pairs well with the increased activity that supports treatment overall. For specific nutritional support alongside the injection, guidance on supplements during semaglutide treatment covers some of the nutrients that can fall short when appetite is reduced.

One practical detail worth knowing: taking your weekly injection consistently on the same day (for many people that becomes a Saturday morning ritual) keeps your dosing steady, which in turn keeps GI side effects more predictable than erratic timing would.

When symptoms need more than a dietary tweak

Most bowel changes on semaglutide resolve without intervention. But some symptoms are a signal to get proper medical input.

Severe diarrhoea that lasts more than a day or two can lead to dehydration and, in turn, put pressure on the kidneys, the NHS flags kidney problems as a possible consequence of significant fluid loss on GLP-1 medicines. Signs of dehydration include a dry mouth, dizziness when standing, and noticeably dark urine. If you can't keep fluids down at all, contact your GP or call 111.

More urgently: severe stomach pain that doesn't ease, particularly pain that spreads to the back, with or without vomiting, requires same-day medical attention. The MHRA issued a Drug Safety Update in January 2026 reminding patients and prescribers that acute pancreatitis (though uncommon) is a known risk with GLP-1 medicines. That pain pattern is a warning sign, not ordinary indigestion.

Bowel changes that persist well beyond a dose increase, or that are severe from the outset, are also worth discussing with a prescriber rather than managing alone. The semaglutide dose escalation schedule exists partly to reduce the intensity of side effects, if symptoms are disproportionate, the pace of titration may need reviewing.

You can report any suspected side effect through the MHRA Yellow Card scheme, which helps regulators monitor real-world safety data for medicines like semaglutide.

What helps, and what to avoid

Small, practical adjustments make a meaningful difference to GI tolerability on semaglutide. Eating smaller meals rather than large ones reduces the load on a stomach that's already emptying slowly. Rich, fatty or spicy foods tend to aggravate nausea and loose stools in the early weeks, so many people find plain, easy foods more comfortable at first.

Alcohol is worth limiting for a different reason: it can mask nausea and worsen dehydration, compounding bowel symptoms rather than easing them. Some supplements also interact with semaglutide's absorption or GI tolerability, it's worth checking which supplements to avoid while taking semaglutide before adding anything new to your routine.

If cost is a factor in whether you start or continue treatment, the Wegovy cost context page explains what a legitimate private prescription includes, relevant given that the medicine requires consistent supply to be effective. Stopping and restarting is harder on the gut than steady, supervised treatment.

If your symptoms are making you question whether to continue, that conversation belongs with a prescriber, not a forum. Our team at the nume clinical team reviews every patient's progress, and bowel-related concerns are genuinely common, there's nothing unusual about raising them. When you're ready to discuss your options, speaking to our prescribers is the straightforward next step.